SpacDeskVesicor Therapeutics, Inc.
Combination Announced · 1 SPAC · 0 closed · 1 announced
Black Hawk Acquisition Corp (Nasdaq: BKHA) is a blank-check vehicle that announced a definitive business combination with Vesicor Therapeutics, Inc. on April 29, 2025. The proposed transaction would bring Vesicor, a therapeutics-focused company operating in the diversified sector, to the public markets through the SPAC structure. The deal is currently in the combination-announced stage, pending the customary shareholder votes and regulatory clearances required before closing can proceed. Investors and analysts tracking BKHA and the broader SPAC market can sign up at SpacDesk for full filing data, deal timelines, sponsor details, and comparable transaction analytics.
Announced
2025-04-29
Expected Close
—
PIPE Raised
—
Industry
Other / Diversified
SPAC Counterparty (1)
| Symbol | Issuer | Status | Announced | Close | IPO Size | PIPE | Sponsor |
|---|---|---|---|---|---|---|---|
| BKHA | Black Hawk Acquisition Corp | Combo Announced | 2025-04-29 | — | $69.3M | — | Black Hawk Management LLC |
Key Filings
| Form | Filed | SPAC | Accession |
|---|---|---|---|
| S-4/A | 2026-06-11 | BKHA | 0001829126-26-006338 |